米国市場銘柄情報

INCY インサイト

銘柄追加

53.760
+0.670+1.26%

終値 05/03 16:00 ET

53.930
+0.170+0.32%

市場後 19:07 ET

120.71億時価総額16.29直近PER

インサイトに関するコメント

ログインコメントを投稿

Moomoo AI

02/28 01:21

Significant insider selling at Incyte and lack of purchases over the last year may suggest insiders don't view shares as a bargain. The history of sales makes us cautious about the stock.

Possible Bearish Signals With Incyte Insiders Disposing Stock

Moomoo AI

02/01 19:06

Despite a recent earnings dip, Incyte's high P/E ratio indicates investor anticipation of strong future growth. This is expected to continue bolstering the share price unless earnings significantly deteriorate.

Investors Interested In Incyte Corporation's (NASDAQ:INCY) Earnings

Moomoo AI

2023/12/10 20:28

Incyte's seemingly unimpressive ROE contradicts its strong net income growth and high reinvestment rate, indicating a healthier financial condition. Future earnings growth, hinging on efficient profit reinvestment, is expected to sustain.

Incyte Corporation (NASDAQ:INCY) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Moomoo AI

2023/11/06 22:21

The relevance of a major insider selling at a high price may be limited to the stock's current position. With limited insider ownership, Incyte illustrates only a moderate alignment with other shareholders. Promising signs would include future substantial insider purchases.

68% Of This Incyte Insider's Holdings Were Sold

Moomoo AI

2023/10/07 22:19

Despite Incyte becoming profitable with steady revenue growth, its consistent share price drop could concern investors. Consider analyst consensus estimates and Incyte's 2 warning signs before making investment decisions.

The Past Three Years for Incyte (NASDAQ:INCY) Investors Has Not Been Profitable

GAME_DAY

2023/08/03 04:39

Daily alerts recap 🔥

$ペイパル(PYPL.US)$$ウィン・リゾーツ(WYNN.US)$$モルソン・クアーズ・ビバレッジ(TAP.US)$$インサイト(INCY.US)$$Yellow(YELL.US)$$フォルテ・バイオサイエンシズ(FBRX.US)$$アプライド・セラピューテクス(APLT.US)$$Adamis Pharmaceuticals(ADMP.US)$

GAME_DAY

2023/08/03 01:54

Current watch ⚡️

$モルソン・クアーズ・ビバレッジ(TAP.US)$$インサイト(INCY.US)$$ペイパル(PYPL.US)$$アドバンスト・マイクロ・デバイス(AMD)(AMD.US)$$マッチ・グループ・インク(MTCH.US)$$アプライド・セラピューテクス(APLT.US)$$ティースタンプ(IDAI.US)$$Aurora Acquisition Corp(AURC.US)$$Yellow(YELL.US)$$バーテックス・ファーマシューティカルズ(VRTX.US)$

Movers and Shakers

2023/08/01 20:27

コラムToday's Pre-Market Stock Movers And Top Ratings: GAP, UBER, SOFI, EL and More

Pre-Market Stock Movers
Gapping up
$ギャップ(GPS.US)$
(The retail stock climbed nearly 4% after Barclays upgraded Gap to overweight from equal weight. Analyst Adrienne Yih assigned a $13 price target to the company, which suggests shares could rally 26.2% from Monday's close. )
$インサイト(INCY.US)$
(Shares rose 2% after Incyte beat analysts' expectations in its latest results. The pharmaceutical company reported second-q...

Alvinnnnnnngenius

2023/06/23 11:12

I expect this to hit 52 high week soon insider keep loading

$インサイト(INCY.US)$

Analysts Notebook

2023/05/04 20:04

コラムUS Top Rating Updates on 5/4: PACW, INCY, QRVO, NBIX and More

Citigroup Downgrades Wingstop to Neutral, Raises Price Target to $224
Citigroup analyst Jon Tower downgrades $ウイング・ストップ(WING.US)$ from Buy to Neutral and raises the price target from $204 to $224.
ZoomInfo Technologies Initiated at Buy by DA Davidson
$ズームインフォ・テクノロジーズ(ZI.US)$ Price Target Announced at $30.00/Share by DA Davidson.
PacWest Downgraded to Neutral From Buy by DA Davidson
$PacWest Bancorp(PACW.US)$ Downgraded to Neutral From Buy, Sto...

まだコメントはありません

分析

アナリスト評価

データなし

目標株価

データなし

ホット

米国株

総合人気

テーマ

CAR-T療法

日中+1.56%